BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28452443)

  • 21. Fractional solute removal and KT/V in different modalities of renal replacement therapy.
    Waniewski J; Lindholm B
    Blood Purif; 2004; 22(4):367-76. PubMed ID: 15297787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An integrative description of dialysis adequacy indices for different treatment modalities and schedules of dialysis.
    Debowska M; Waniewski J; Lindholm B
    Artif Organs; 2007 Jan; 31(1):61-9. PubMed ID: 17209962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urea is the best molecule to target adequacy of peritoneal dialysis.
    Gotch FA
    Perit Dial Int; 2000; 20 Suppl 2():S58-64. PubMed ID: 10911645
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dialysis adequacy indices for peritoneal dialysis and hemodialysis.
    Debowska M; Waniewski J; Lindholm B
    Adv Perit Dial; 2005; 21():94-7. PubMed ID: 16686294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Routine assessment of kidney urea clearance, dialysis dose and protein catabolic rate in the once-weekly haemodialysis regimen.
    Casino FG; Deira J; Suárez MA; Aguilar J; Basile C
    J Nephrol; 2021 Dec; 34(6):2009-2015. PubMed ID: 33891294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival comparison between hemodialysis and peritoneal dialysis based on matched doses of delivered therapy.
    Keshaviah P; Collins AJ; Ma JZ; Churchill DN; Thorpe KE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S48-52. PubMed ID: 11792762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adequacy in dialysis: intermittent versus continuous therapies.
    Misra M; Nolph KD
    Nefrologia; 2000; 20 Suppl 3():25-32. PubMed ID: 10835874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of two methods for predicting equilibrated Kt/V (eKt/V) using true eKt/V value.
    Marsenić O; Peco-Antić A; Jovanović O
    Pediatr Nephrol; 1999 Jun; 13(5):418-22. PubMed ID: 10412862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analysis of adequacy of dialysis in a selected population on CAPD for over 3 years: the influence of urea and creatinine kinetics.
    Selgas R; Bajo MA; Fernandez-Reyes MJ; Bosque E; Lopez-Revuelta K; Jimenez C; Borrego F; de Alvaro F
    Nephrol Dial Transplant; 1993; 8(11):1244-53. PubMed ID: 8302464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Small-solute and middle-molecule clearances during continuous flow peritoneal dialysis.
    Leypoldt JK; Burkart JM
    Adv Perit Dial; 2002; 18():26-31. PubMed ID: 12402582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis dose (Kt/V) and clearance variation sensitivity using measurement of ultraviolet-absorbance (on-line), blood urea, dialysate urea and ionic dialysance.
    Uhlin F; Fridolin I; Magnusson M; Lindberg LG
    Nephrol Dial Transplant; 2006 Aug; 21(8):2225-31. PubMed ID: 16611681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting treatment dose for novel therapies using urea standard Kt/V.
    Leypoldt JK; Jaber BL; Zimmerman DL
    Semin Dial; 2004; 17(2):142-5. PubMed ID: 15043617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accuracy of using 30-minute post-dialysis BUN to determine equilibrated Kt/V.
    Chirananthavat T; Tungsanga K; Eiam-Ong S
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S54-64. PubMed ID: 17044455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urea standard Kt/V(urea) for assessing dialysis treatment adequacy.
    Leypoldt JK
    Hemodial Int; 2004 Apr; 8(2):193-7. PubMed ID: 19379417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KT/V: the denominator dilemma.
    Lindholm B; Waniewski J; Weryński A
    Pol Merkur Lekarski; 2003 Oct; 15(88):311-5. PubMed ID: 14974355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daily hemodialysis efficiency: an analysis of solute kinetics.
    Depner TA
    Adv Ren Replace Ther; 2001 Oct; 8(4):227-35. PubMed ID: 11593488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of long-term survival between hemodialysis and peritoneal dialysis.
    Maiorca R; Cancarini GC; Brunori G; Zubani R; Camerini C; Manili L; Movilli E
    Adv Perit Dial; 1996; 12():79-88. PubMed ID: 8865878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of dialysis dose during combination therapy with peritoneal dialysis and hemodialysis.
    Kawanishi H; Moriishi M; Tsuchiya S
    Adv Perit Dial; 2007; 23():135-9. PubMed ID: 17886620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface-area-normalized Kt/V: a method of rescaling dialysis dose to body surface area-implications for different-size patients by gender.
    Daugirdas JT; Depner TA; Greene T; Kuhlmann MK; Levin NW; Chertow GM; Rocco MV
    Semin Dial; 2008; 21(5):415-21. PubMed ID: 18945330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Volume of urea cleared as a therapy dosing guide for more frequent hemodialysis.
    Leypoldt JK; Weinhandl ED; Collins AJ
    Hemodial Int; 2019 Jan; 23(1):42-49. PubMed ID: 30255600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.